Castle Biosciences | Evaluate

November 18, 2022

Big medtechs’ efficiency starts to recover from Covid

Orthopaedics and cardiology groups start to improve in terms of sales per employee, but Covid test makers do better still.

January 08, 2021

A tale of two Covids for smaller device makers

The pandemic provided the best and worst of times for smid-cap medtechs.

January 21, 2020

Poor fourth quarter mars strong year for medtech floats

The device sector enjoyed a mid-year IPO bonanza, but after getting away the class of 2019 had a torrid time.